Prevention of hepatorenal toxicity with Sonchus asper in gentamicin treated rats by Khan, Muhammad R et al.
RESEARCH ARTICLE Open Access
Prevention of hepatorenal toxicity with Sonchus
asper in gentamicin treated rats
Muhammad R Khan
*, Iram Badar
† and Aisha Siddiquah
†
Abstract
Background: Sonchus asper possesses antioxidant capacity and is used in liver and kidney disorders. We have
investigated the preventive effect of methanolic extract of Sonchus asper (SAME) on the gentamicin induced
alterations in biochemical and morphological parameters in liver and kidneys of Sprague-Dawley male rat.
Methods: Acute oral toxicity studies were performed for selecting the therapeutic dose of SAME. 30 Sprague-
Dawley male rats were equally divided into five groups with 06 animals in each. Group I received saline (0.5 ml/kg
bw; 0.9% NaCl) while Group II administered with gentamicin 0.5 ml (100 mg/kg bw; i.p.) for ten days. Animals of
Group III and Group IV received gentamicin and SAME 0.5 ml at a dose of 100 mg/kg bw and 200 mg/kg bw,
respectively while Group V received only SAME at a dose of 200 mg/kg bw. Biochemical parameters including
aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP), lactate dehydrogenase (LDH),
g-glutamyltransferase (g-GT), total cholesterol, triglycerides, total protein, albumin, creatinine, blood urea nitrogen
(BUN), total bilirubin and direct bilirubin were determined in serum collected from various groups. Urinary out puts
were measured in each group and also assessed for the level of protein and glucose. Lipid peroxides (TBARS),
glutathione (GSH), DNA injuries and activities of antioxidant enzymes; catalase (CAT), peroxidase (POD) and
superoxide dismutase (SOD) were determined in liver and renal samples. Histopathological studies of liver and
kidneys were also carried out.
Results: On the basis of acute oral toxicity studies, 2000 mg/kg bw did not induce any toxicity in rats, 1/10
th of
the dose was selected for preventive treatment. Gentamicin increased the level of serum biomarkers; AST, ALT, ALP,
LDH, g-GT, total cholesterol, triglycerides, total protein, albumin, creatinine, BUN, total and direct bilirubin; as were
the urinary level of protein, glucose, and urinary output. Lipid peroxidation (TBARS) and DNA injuries increased
while GSH contents and activities of antioxidant enzymes; CAT, POD, SOD decreased with gentamicin in liver and
kidney samples. SAME administration, dose dependently, prevented the alteration in biochemical parameters and
were supported by low level of tubular and glomerular injuries induced with gentamicin.
Conclusion: These results suggested the preventive role of SAME for gentamicin induced toxicity that could be
attributed by phytochemicals having antioxidant and free radical scavenging properties.
Background
Gentamicin is an aminoglycoside, natural or semisyn-
thetic antibiotic clinically used against Gram negative
bacteria because of its efficacy and failure to increase
bacterial resistance. However, the main problem asso-
ciated with gentamicin is the cause of nephrotoxicity at
its therapeutic doses and appeared to be a major cause
of nonoliguric acute renal failure [1]. Gentamicin is
excreted through kidneys without degradation or meta-
bolic changes, with 5 to 10% dose is concentrated in
proximal tubules vastly exceeding the concurrent serum
concentration [2]. Although its exact role in kidney dys-
function is not apparent, it is suggested that the selec-
tive accumulation of gentamicin in kidney cortex can
induce oxidative stress and cause lipid peroxidation [3].
Additionally, it can mediate the generation of reactive
oxygen species (ROS) such as hydroxyl radical, hydrogen
peroxide and superoxide anion mostly in mitochondria
that can induce renal injuries [3].
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factor ensuing local vasoconstriction and thus reduces
the renal blood flow and glomerular filtration rate [4].
Gentamicin induced renal injuries are mostly localized
to the proximal tubules because of association of genta-
micin with polyanionic inositol phospholipids and mega-
lin,ar e c e p t o r ,f o ru p t a k eo fg e n t a m i c i n[ 5 , 6 ] .
Gentamicin resists the degradation of phospholipids that
compromised the lysosomal membrane integrity and
eventually the leakage of enzymes. Gentamicin behaves
as iron chelator and iron-gentamicin complexes are
thought to be involved in free radical formation [7].
Iron, released from the renal cortex mitochondria on
account of excessive oxidative stress induced with genta-
micin, act as a putative enhancer of gentamicin induced
oxidative stress. Oxidative stress is mainly regulated by
the cellular enzymatic (catalase, superoxide dismutase,
glutathione peroxidase) and nonenzymatic (glutathione,
ascorbic acid, a-tocopherol) factors [7].
Recent studies have shown that natural antioxidants
obtained from different alternative systems of medicine
display a wide range of biological activities. Various
alternatives possessing antioxidant properties have been
used in order to minimize gentamicin induced oxidative
stress in animal models. Many plant extracts have been
reported to be effective in ameliorating organ toxicities
[8-11]. Prevention of nephrotoxicity induced with genta-
micin in rat by grape seed extract might be attributed
by the presence of polyphenolic compounds [8]. Green
tea extract possesses catechin and other polyphenolic
compounds; prevents the gentamicin induced nephro-
toxicity in rat [10,11]. Momordica dioica extract also
prevented the toxic insult caused by gentamicin in rat
[12]. Coenzyme Q10 played a significant role in protect-
ing cells from oxidative stress induced with gentamicin
and other agents [9,13]. Another antioxidant that possi-
bly deactivates ROS is curcumin. This chemical is
obtained from Curcuma longa; decreased the oxidative
stress induced with gentamicin and is also found benefi-
cial against AIDS [14,15]. Erdosteine, a mucolytic agent
also impart free radical scavenging and antioxidant
activities against gentamicin induced nephrotoxicity and
other pharmacological or noxious agents [16,17]. Experi-
mental data suggest that renoprotective effects of plant
extracts or chemicals are mainly attributed through anti-
oxidant/scavenging of free radicals, metal chelation and
stabilizing the membranous system [11].
Sonchus asper grows wild in fields and also in waste-
lands in Pakistan. This plant is locally utilized in renal
disorders [18]. Marked renoprotective effects of metha-
nol extract of Sonchus asper against carbon tetrachloride
induced injuries are reported in our previous studies
[19]. Similarly methanolic extract of Sonchus asper is
found beneficial in decreasing the oxidative stress
induced with potassium bromated in cardiovascular sys-
tem of rat [20]. Chemical characterization of Sonchus
asper revealed the presence of polyphenolics such as
rutin, quercetin, catechin and myricetin [21,22]. Since
liver and kidneys are involved in the metabolism and
excretion of xenobiotics, these may be more prone to
various pathological conditions. The inability of conven-
tional medicine to minimize the gentamicin induced
oxidative damage has contributed for the use of comple-
mentary medicine. However, no studies have been per-
formed on the antioxidant potential of Sonchus asper
against the oxidative stress caused by gentamicin. There-
fore, this study was designed to investigate whether the
methanolic extract of Sonchus asper ameliorates the
hepatorenal toxicity induced with gentamicin in rat
model.
Methods
Preparation of plant extract
Whole plant (leaves, stem, flowers, seeds and roots) of
Sonchus asper at maturity was collected from District
Rawalpindi and after identification a specimen was sub-
mitted at herbarium of Pakistan, Quaid-i-Azam Univer-
sity Islamabad Pakistan. Shade dried powdered (2 kg)
was extracted twice with methanol for three days. The
methanolic solution was filtered and dried in rotary eva-
porator to get the crude methanol extract of Sonchus
asper (SAME).
Acute toxicity studies
Acute oral toxicity studies were carried out on 150-200 g
body weight of Sprague-Dawley male rats according to
defined doses (5, 50, 300, 2000 mg/kg bw) to the over-
night fasted rats but water was provided ad libitum.T h e
onset and sign of toxicity were noted for each dose for
three days. Since the dose of 2000 mg/kg bw did not
induce any sign of toxicity, it was selected for the preven-
tive effects against the gentamicin treatment to rats [23].
Animals and experimental protocols
30 Sprague-Dawley male rats (160-200 g) were acquired
from National Institute of Health (NIH) Islamabad. Ani-
mals were kept at the Primate Facility maintained at
Quaid-i-Azam University Islamabad in ordinary cages
for two weeks at room temperature of 25 ± 3°C with a
12 h dark/light cycle for acclimatization. Animals had
free access to food and water ad libitum.T h ee x p e r i -
mental protocol and procedures used in this study were
approved by the Ethics committee of the Quaid-i-Azam
University, Islamabad, Pakistan for the care and use of
laboratory animals. Dose of gentamicin was given as
described previously [24]. Rats were divided into five
groups (n = 06 rats per group) with the following
protocols:
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NaCl) orally
Group II: gentamicin (0.5 ml) administered at a dose
of 200 mg/kg bw intraperitoneally
Group III: rats received gentamicin and 0.5 ml of
SAME (100 mg/kg bw) orally through a feeding tube by
lowering in the stomach.
Group IV: animals treated with gentamicin and 0.5 ml
SAME (200 mg/kg bw; orally)
Group V: animals received 0.5 ml of SAME only (200
mg/kg bw; orally)
All these treatments were given to rats for ten days.
Animals were anesthetized with ether, 24 h after the last
treatment, blood was collected through cardiac punc-
ture, centrifuged at 1500 × g for 10 min, at 4°C to col-
lect serum.
Histopathological studies of liver and kidneys
Liver and kidneys were perfuse with cold saline at 4°C
and excised immediately. For histological studies a por-
tion of liver and kidney was fixed in sera (absolute alco-
hol 60%, formaldehyde 30%, glacial acetic acid 10%).
Liver function tests
Analysis of serum was carried out for alanine transami-
nase (ALT), aspartate transaminase (AST), alkaline
phosphatase (ALP), lactate dehydrogenase (LDH) and
gamma glutamyltransferase (g-GT) with standard AMP
diagnostic kits (Stattogger Strasse 31b 8045 Graz,
Austria).
Serum analysis for biochemical studies
Level of blood urea nitrogen (BUN), creatinine, total
protein, albumin, total bilirubin, direct bilirubin, total
cholesterol, triglycerides in serum was determined by
using standard AMP diagnostic kits (Stattogger Strasse
31b 8045 Graz, Austria).
Antioxidant enzyme assays in hepatic and renal samples
Hepatic and renal tissues were homogenized in 10
volume of phosphate buffer (100 mM) having EDTA
(pH 7.4; 1 mM), centrifuged (12000 × g) at 4°C for 30
min. Supernatant was used to estimate the protein con-
tents by using bovine serum albumin (BSA) as standard
[25]. Catalase (CAT) and peroxidase (POD; 1.11.1.7)
activity was estimated by following the method of
Chance and Maehly (1955) [26] in liver and renal homo-
genates. In this experiment hydrogen peroxide was used
as substrate for catalase activity while guaiacol was used
for peroxidase activity. However, superoxide dismutase
(SOD) activity was determined according to the proce-
dure described previously [27].
Estimation of renal glutathione (GSH) and lipid
peroxidation (TBARS)
Hepatic and renal glutathione (GSH) contents were
determined according to the method described pre-
viously [28] by using DTNB (5,5-dithiobis-2-nitroben-
zoic acid) as substrate. Level of lipid peroxidation
(TBARS) in renal homogenates was determined
according to the method described by Iqbal et al.
(1996) [29] using thiobarbituric acid as reacting
substrate.
DNA fragmentation assay
For DNA fragmentation estimation, liver and renal tis-
sue was homogenized in 10 volumes of a TE solution
pH 8.0 (5 mM Tris-HCl, 20 mM EDTA), 0.2% triton X-
100 and centrifuged at 27,000 × g for 20 min to separate
the intact chromatin (pellet A) from the fragmented
(supernatant B) [30]. 1.0 ml aliquot of each sample was
centrifuged at 27,000 × g for 20 min. Quantification of
DNA for the intact chromatin and fragmented chroma-
tin was determined by using freshly prepared DPA
(Diphenylamine) solution and optical density was
recorded at 620 nm with SmartSpec Spectrophotometer.
Quantity of fragmented DNA was estimated by using
the following formula:
% fragmented DNA = B × 100/(A+B )
DNA ladder assay
DNA was isolated from the liver and renal tissues by
following the method described previously [30]. 5 μgo f
DNA of both organs was loaded in 1.5% agarose gel
containing 1.0 μg/ml ethidium bromide. After electro-
phoresis gel was studied under gel doc system and was
photographed.
Analysis of urine
After the last treatment animals were shifted to meta-
bolic cages for 24 h in order to collect their urine indivi-
dually and to estimate urine volume. Urine samples
were assayed for glucose and protein by using standard
diagnostic kits (MediScreen Orgenics, France).
Statistical analysis
Data recorded was analyzed for the mean and standard
deviation in each group. Differences between groups
were determined by performing one way analysis of var-
iance and post hoc comparison in terms of least signifi-
cance difference (LSD) at 0.05 and 0.01 by using the
Statistical Package for Social Sciences (SPSS) software
for Windows (version 14.0).
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Effect of SAME on liver marker enzymes
Gentamicin increased the level of biochemical para-
meters; AST, ALT, ALP, LDH and g-GT in serum as
compared to that of the control group (Table 1). Treat-
ment of SAME in combination with gentamicin reduced
t h es e r u ml e v e lo fA S T ,A L T ,A L P ,L D Ha n dg-GT,
dose dependently, to that of the gentamicin treated
group. Treatment of SAME (200 mg/kg bw) alone did
not induce significant (P>0.05) change in the level of
liver marker enzymes as compared to control group.
Effect of SAME on serum biochemistry
Injection of gentamicin to rats for ten days significantly
(P < 0.01) decreased the serum level of total protein and
albumin while the level of total cholesterol, triglycerides,
total and direct bilirubin increased than that of the con-
trol group (Table 2). In addition, altered level of these
parameters induced with gentamicin in serum was
restored, dose dependently, with the simultaneous treat-
ment of SAME to rats than that of the control group.
However, administration of SAME alone to rats did not
cause any significant (P>0.05) change in the parameter
studied as compared to the control group (Table 2).
Effects of SAME on urinary protein, glucose and urine
output in rat
Effect of gentamicin and gentamicin plus SAME on
urinary protein, glucose and urine output are shown in
Table 3. Urinary excretion of protein, glucose and urin-
ary output significantly increased with gentamicin than
that of the control group. Administration of SAME in
combination with gentamicin ameliorated the toxicity of
gentamicin and the level of protein, glucose and urinary
output significantly reduced, as compared to that of the
gentamicin treated group. However, non significant
(P>0.05) alteration in the level of urinary protein, glu-
cose and in urine output was recorded with the SAME
administration alone as compared to the control group.
Effects of SAME on hepatorenal antioxidant enzymes of
rat
Effects of gentamicin, and gentamicin plus SAME on
hepatorenal antioxidant defense system such as CAT,
POD and SOD are shown in Table 4 and 5. Administra-
tion of gentamicin significantly (P < 0.01) decreased the
activities of both hepatic and renal CAT, POD and SOD
as compared to control group. Treatment of SAME
along with gentamicin increased the activity level of
CAT, POD and SOD, dose dependently, as compared to
the gentamicin treated group. However, non significant
(P>0.05) change was recorded with the treatment of
SAME alone as compared to control group.
Effects of SAME on hepatorenal TBARS, GSH and DNA
fragmentation in rat
Table 6 and 7 show the effects of SAME on TBARS,
GSH and DNA fragmentation in liver and renal samples.
Table 1 Effects of SAME on liver marker profile in rat
Treatment AST U/l ALT U/l ALP U/l LDH U/l g-GT U/l
Control (Saline, 0.9% NaCl) 83.3 ± 9.3A 34.3 ± 4.0A 246.7 ± 16.3A 50.8 ± 6.9A 69.8 ± 6.8A
GTM (100 mg/kg bw) 182.6 ± 18.3D 68.9 ± 8.0D 366.3 ± 26.7E 64.3 ± 7.0C 94.2 ± 8.8D
GTM + SAME (100 mg/kg bw) 148.9 ± 17.6C 63.8 ± 5.6C 311.3 ± 17.8D 59.5 ± 6.2B 84.6 ± 7.6C
GTM + SAME (200 mg/kg bw) 122.1 ± 10.6B 51.0 ± 6.9B 263.7 ± 19.0C 49.0 ± 4.8A 79.5 ± 6.8BC
SAME (200 mg/kg bw) 83.5 ± 6.8A 35.6 ± 5.9A 240.7 ± 13.8A 49.7 ± 6.3A 72.6 ± 7.3A
Mean ± SD (n = 06). A-D, Means not sharing common letters within a column are significantly (P < 0.01) different from each other
GTM, gentamicin; SAME, methanol extract of Sonchus asper
Table 2 Effects of SAME on serum chemistry in rat
Treatment Total
protein
(mg/dl)
Albumin
(mg/dl)
Triglycerides
(mg/dl)
Total
cholesterol
(mg/dl)
Total
bilirubin
(mg/dl)
Direct
bilirubin
(mg/dl)
Urea (mg/dl) Creatinine (mg/dl)
Control
(Saline, 0.9% NaCl)
42.5 ± 4.7A 22.7 ± 3.5A 12.8 ± 2.8A 6.8 ± 0.84A 1.51 ± 0.36A 0.87 ± 0.14A 33.5 ± 5.7A 0.78 ± 0.16A
GTM (100 mg/kg bw) 33.7 ± 3.7D 16.4 ± 2.3D 18.6 ± 2.0B 12.0 ± 2.95D 2.83 ± 0.45D 1.17 ± 0.44E 56.2 ± 6.6C 3.7 ± 0.60C
GTM + SAME
(100 mg/kg bw)
35.7 ± 4.1C 18.4 ± 2.8C 17.2 ± 2.2B 10.1 ± 1.73CD 1.69 ± 0.34C 1.03 ± 0.16C 43.2 ± 5.2BC 2.6 ± 0.65B
GTM + SAME
(200 mg/kg bw)
40.2 ± 5.6B 21.1 ± 3.2AB 13.1 ± 2.2A 8.8 ± 1.50B 1.67 ± 0.24C 0.97 ± 0.17B 40.6 ± 6.2B 1.2 ± 0.26A
SAME (200 mg/kg bw) 43.2 ± 4.2A 23.2 ± 2.9A 12.1 ± 1.4A 7.2 ± 1.69A 1.49 ± 0.36A 0.83 ± 0.16A 32.4 ± 4.6A 0.84 ± 0.32A
Mean ± SD (n = 06). A-D, Means not sharing common letters within a column are significantly (P < 0.01) different from each other.
GTM, gentamicin; SAME, methanol extract of Sonchus asper
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decreased the level of GSH while increased (P < 0.01)
the level of TBARS and DNA fragmentation as com-
pared to the control group. Administration of SAME in
combination with gentamicin significantly reversed the
level of GSH, TBARS and DNA injuries as compared to
gentamicin treated group in a dose dependent manner
in both the liver and kidney samples. Treatment of
SAME alone did not cause any significant (P>0.05)
change in the level of GSH, TBARS and DNA injuries
in renal samples.
Effects of SAME on DNA ladder assay
DNA ladder assay showed a continuous banding pattern
of fragmented DNA induced with gentamicin in both
the organs; liver and kidneys (Figure 1). DNA injuries
were comprehensively eliminated by the SAME treat-
ment in liver and kidney samples. However, DNA frag-
mentation was not recorded in the control samples of
liver and kidneys.
Histopathological studies of liver
Liver of animal in the control group showed normal
hepatic architecture, where the hepatocytes are arranged
around the central vein and alternate with blood sinu-
soids. Each hepatic cell possesses a limiting membrane,
centrally placed large nucleus and prominent nucleoli
(Figure 2 A). Microscopic examination of animal livers
treated with gentamicin depicted marked hepatocellular
changes, dilated and congested sinusoids with hemor-
rhage (Figure 2B). Treatment of SAME along with gen-
tamicin exhibited reversal of these changes (Figure 2C,
D). However, preventive effects were more pronounced
at higher dose of SAME (200 mg/kg bw). Light micro-
scopic examination of H&E stained slides of the group
having 200 mg/kg bw of SAME alone showed normal
architecture of liver hepatic cords and plates radiating
out from the central vein (Figure 2E).
Histopathological studies of kidneys
Histopathological studies of kidneys showed the normal
architecture including glomerulus, bowman capsule, dis-
tal and proximal convoluted tubules. Treatment of gen-
tamicin markedly disrupted the histology as evidenced
by the tubular degeneration, tubular congestion, tubular
dilatation and glomerular injuries (Figure 3B,C). Preven-
tion of nephropathological injuries was determined with
SAME to gentamicin treated rats (Figure 3D).
Discussion
Gentamicin is a therapeutic agent used against the life
threatening infections in human, but it causes acute
renal failure in 10-15% of the patients [31] while more
than 30% of the patients showed the signs of nephro-
toxicity which have received the gentamicin for more
than 7 days [32,33]. In this study we have tested the
hypothesis that SAME administration could prevent
gentamicin induced hepatorenal toxicity in rat.
Treatment of gentamicin causes significant increase in
the serum level of liver and kidney function markers
such as creatinine, BUN, total cholesterol, triglycerides,
total bilirubin, and direct bilirubin as compared to
respective control indicating hepatorenal dysfunction.
These injuries could be due to the production of free
radicals and involvement of oxidative stress to hepatore-
nal toxicity caused by gentamicin treatment. Gentamicin
Table 3 Effects of SAME on urinary profile of rat
Treatment Urinary volume (ml/day) Urinary glucose (mg/L/day) Urinary protein (mg/L/day)
Control (Saline, 0.9% NaCl) 7.4 ± 1.24A 9.4 ± 1.2A 16.5 ± 2.62A
GTM (100 mg/kg bw) 14.6 ± 3.24C 53.8 ± 7.4D 38.8 ± 7.16B
GTM + SAME (100 mg/kg bw) 11.5 ± 2.76B 42.9 ± 5.4C 28.9 ± 4.32B
GTM + SAME (200 mg/kg bw) 9.3 ± 2.22A 25.5 ± 3.4B 19.8 ± 3.16A
SAME (200 mg/kg bw) 8.3 ± 1.63A 8.4 ± 1.3A 16.31 ± 4.25A
Mean ± SD (n = 06). A-D, Means not sharing common letters within a column are significantly (P < 0.01) different from each other.
GTM, gentamicin; SAME, methanol extract of Sonchus asper
Table 4 Effects of SAME on liver antioxidant enzymes of rat
Treatment CAT (U/mg protein) POD (U/mg protein) SOD (U/mg protein)
Control (Saline, 0.9% NaCl) 10.3 ± 1.5A 12.7 ± 1.2A 21.2 ± 2.5A
GTM (100 mg/kg bw) 5.8 ± 1.0B 6.8 ± 0.9D 13.2 ± 1.6C
GTM + SAME (100 mg/kg bw) 8.8 ± 1.0A 8.4 ± 1.2C 16.7 ± 1.2B
GTM + SAME (200 mg/kg bw) 9.8 ± 1.2A 10.4 ± 1.5B 20.2 ± 1.9A
SAME (200 mg/kg bw) 10.3 ± 0.9A 12.8 ± 1.3A 22.3 ± 1.6A
Mean ± SD (n = 06). A-D, Means not sharing common letters within a column are significantly (P < 0.01) different from each other.
GTM, gentamicin; SAME, methanol extract of Sonchus asper
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thereby enhancing the level of total cholesterol, trigly-
cerides, total and direct bilirubin, BUN and creatinine in
serum. Oxidative damage to kidneys by gentamicin may
also contribute for the observed higher concentration of
BUN and creatinine in serum. The same results have
been reported in earlier studies where they have sug-
gested the kidney dysfunction caused by gentamicin oxi-
dative stress [8,13]. However, gentamicin treatment
causes depletion in total protein and albumin, useful
markers of liver function, might be depressed as a result
of defective protein synthesis. Co-administration of
SAME along with gentamicin caused significant decrease
in the concentration of creatinine, BUN, total choles-
terol, triglycerides, total bilirubin, and direct bilirubin
while a significant increase in albumin and total protein
of serum suggested the protective effects of SAME.
Similar protective studies of different extracts against
gentamicin have been reported previously [8,11,12].
Urinalysis also provides important clues about the
functional status of kidneys. In this regard significantly
higher quantity of urine volume, urinary glucose, and
protein was recorded with gentamicin administration
to rat for 10 days. At large scale excretion of gentami-
cin from kidneys, intracellular accumulation of genta-
micin is confined primarily in the S1 and S2 segment
of proximal convoluted tubules and can cause injuries
[5,31,34]. These results are associated with significant
excretion of urinary protein, glucosuria and urine out-
put simulating the leakage and defects in reabsorption,
and could be due to proximal tubular structural
damage observed in this study. Histopathological
examination of the gentamicin treated kidneys for 10
days indicated the presence of lesions in cortex with
specifically in proximal convoluted tubules. Gentamicin
probably binds to the negatively charged cationic phos-
phoinositides components of brush border of proximal
tubules and associated with megalin that are taken up
by lysosomes, results in disruption of various processes
[6]. Use of SAME in combination with gentamicin for
10 days ameliorated the hepatorenal toxicity induced
with gentamicin and resulted in the restoration of his-
topathology. Results obtained suggested that preven-
tion of gentamicin induced renal toxicity with SAME
at two different doses, mightb ed u et ot h ep r e s e n c eo f
various bioactive phytochemicals in the extract that
may regulate and repair injured tissues. Similar results
for these parameters were reported in other studies
[8,9,12].
Gentamicin treatment causes hepatotoxicity as clearly
indicated by the significant increase in serum level of
ALT, AST, ALP, LDH and g-GT, than those of control
rats. Serum level of transaminases and ALP is generally
considered as sensitive markers of liver function and
their concentrations are increased in the serum because
of their cytoplasmic nature and are thus released in
blood by changing in the permeability of hepatocyte
membranes. Increased level of LDH in serum in the pre-
sent investigation apparently indicated the toxic effects
of gentamicin in rat. The results obtained in this study
are inconsistent with other reports [14]. Histopathologi-
cal lesions observed in this study correlate the serum
level of liver function enzymes concentration induced
with gentamicin and the possible preventive effects of
Table 5 Effects of SAME on renal antioxidant enzymes of rat
Treatment CAT (U/mg protein) POD (U/mg protein) SOD (U/mg protein)
Control (Saline, 0.9% NaCl) 4.36 ± 0.8A 7.42 ± 1.2A 16.25 ± 3.93A
GTM (100 mg/kg bw) 1.46 ± 0.46D 3.84 ± 0.6D 8.80 ± 1.10B
GTM + SAME (100 mg/kg bw) 2.35 ± 0.7C 4.59 ± 1.4C 10.90 ± 2.22B
GTM + SAME (200 mg/kg bw) 3.30 ± 0.4B 5.53 ± 1.4B 14.68 ± 3.60A
SAME (200 mg/kg bw) 4.31 ± 0.7A 7.14 ± .9A 16.31 ± 2.85A
Mean ± SD (n = 06). A-D, Means not sharing common letters within a column are significantly (P < 0.01) different from each other.
GTM, gentamicin; SAME, methanol extract of Sonchus asper
Table 6 Effects of SAME on hepatic TBARS, GSH and DNA fragmentation of rat
Treatment TBARS (nM
/mg protein)
GSH (μM/g
tissue)
DNA fragmentation%
Control (Saline, 0.9% NaCl) 76.9 ± 3.0A 0.74 ± 0.02A 0.48 ± 0.08A
GTM (100 mg/kg bw) 137.4 ± 6.0D 0.48 ± 0.03D 1.34 ± 0.13D
GTM + SAME (100 mg/kg bw) 116.6 ± 5.4C 0.59 ± 0.03C 1.11 ± 0.10C
GTM + SAME (200 mg/kg bw) 104.9 ± 4.4B 0.68 ± 0.04B 0.88 ± 0.09B
SAME (200 mg/kg bw) 76.1 ± 4.1A 0.76 ± 0.03A 0.40 ± 0.08A
Mean ± SD (n = 06). A-D, Means not sharing common letters within a column are significantly (P < 0.01) different from each other.
GTM, gentamicin; SAME, methanol extract of Sonchus asper
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the improvement in the functional status of liver [14].
Involvement of reactive oxygen species (ROS) in
nephropathies of human are now characterized as a key
element [1]. Gentamicin exposure to rats mediates the
generation of ROS that play a significant role in the pro-
gression of hepatic and renal injuries including array of
biomolecules such as membrane lipids, protein and
nucleic acids especially in some organelles such as mito-
chondria and lysosomes of renal tissues [3]. Increased
propagation of ROS mediates the peroxidation of poly-
unsaturated fatty acids, attached to biomembranes. Gen-
tamicin induced lipid peroxidation impaired the cellular
function and cause necrosis. In this study we observed a
significant increase in the lipid peroxidation product
(TBARS) with gentamicin. Upaganlawar et al. [9] have
suggested that the development of oxidative stress may
involve the release of iron from renal cortical mitochon-
dria and gentamicin catalysis the reaction for the gen-
eration of ROS. Lipid peroxidation of renal tissues
induced with gentamicin was prevented with SAME
treatment. Amelioration of oxidative stress with green
tea and grape seed extract was determined in previous
studies [8,10,11]. Green tea constitutes epicatechin, epi-
catechingallate, epigallocatechin gallate and proanthro-
cyanidine potent antioxidants possibly decrease the
oxidative stress induced with gentamicin [8,10,11]. Simi-
larly the possible preventive effect of SAME, may be due
to the presence of myricetin, quercetin, catechin and
rutin [21,22] very active antioxidants and are known to
play diverse biological roles [35,36]. The results obtained
with SAME for protection of lipid peroxidation are con-
sistent with previous studies [8,11,12].
Table 7 Effects of SAME on renal TBARS, GSH and DNA fragmentation of rat
Treatment TBARS (nM
/mg protein)
GSH (μM/g
tissue)
DNA fragmentation%
Control (Saline, 0.9% NaCl) 58.77 ± 6.4AB 0.82 ± 0.02A 0.21 ± 0.09A
GTM (100 mg/kg bw) 81.07 ± 7.92D 0.56 ± 0.03D 2.14 ± 0.11C
GTM + SAME (100 mg/kg bw) 70.48 ± 6.78C 0.67 ± 0.03C 1.62 ± 0.28C
GTM + SAME (200 mg/kg bw) 61.10 ± 5.82B 0.76 ± 0.04B 0.95 ± 0.14B
SAME (200 mg/kg bw) 59.62 ± 7.03AB 0.84 ± 0.03A 0.22 ± 0.04A
Mean ± SD (n = 06). A-D, Means not sharing common letters within a column are significantly (P < 0.01) different from each other.
GTM, gentamicin; SAME, methanol extract of Sonchus asper
Figure 1 Agarose gel showing DNA damages by gentamicin
and preventive effects of SAME in different groups. Lane from
left (1) DNA marker (2) kidney control (3) liver control (4) gentamicin
100 mg/kg bw of kidney sample (5) gentamicin 100 mg/kg bw of
liver sample (6) gentamicin 100 mg/kg bw + SAME 200 mg/kg bw
of kidney sample (6) gentamicin 100 mg/kg bw + SAME 200 mg/kg
bw of liver sample
Figure 2 Histopathology showing the alterations induced with
gentamicin and preventive effects of SAME in hepatic tissues
of rat. (A) Hepatic section showing the normal architecture of
portal vein (PV) and normal hepatocytes (NH) arranged in
trabaculae. (B) Gentamicin (100 mg/kg bw) induced injuries in liver
with severe level of leucocytes infiltration (LI) and hydropic
degeneration of hepatocytes (HDH). (C) SAME (100 mg/kg bw)
prevents injuries of gentamicin; medium level of leucocytes
infiltration (LI) and bile ductile (BD). (D) SAME (200 mg/kg bw)
prevents injuries of gentamicin; with normal hepatocytes and are
arranged in trabaculae.
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markers of oxidative stress was estimated as a response
to gentamicin induced nephrotoxicity in rat. The none-
nzymatic component of the self defense system; renal
glutathione (GSH) and enzymatic components; CAT,
S O Da n dP O Dw a sd i m i n i s h e din the rats treated with
gentamicin as compared to the respective control group.
Gentamicin enhances the generation of hydrogen perox-
ide, hydroxyl radical and superoxide anion in renal tis-
sues [3] causing oxidative stress. Depletion in the CAT
and SOD after gentamicin exposure has been reported
in other studies suggested that oxidative stress is one of
the cause of renal injuries induced with gentamicin toxi-
city in rat [8,11,12]. Treatment of SAME to rats in com-
bination with gentamicin reversed all these alterations
suggesting that SAME rendered its antioxidant proper-
ties by preventing or scavenging the ROS induced with
gentamicin toxicity. Our results are in accord with other
studies where antioxidant effects of other plants have
been reported against gentamicin induced renal damage
[8,11,12]. Similar protective effects of SAME were
reported in our previous study where carbon tetrachlor-
ide was used as toxic agent [20]. Both carbon tetrachlor-
ide and gentamicin induced nephrotoxicity are
considered to be due to the accumulation of free radi-
cals. The protective mechanism of SAME could be simi-
lar in both kinds of xenobiotics.
The scavenging activity of polyphenolics was postu-
lated to be governed by the position and number of the
hydroxyl groups. Scavenging activity for peroxynitrite
was enhanced with ortho-hydroxyl structures [37]. Fla-
vonoids are oxidized by radicals, resulting in a more
stable, less reactive radical. Flavonoids can also inhibit
the activity of many enzymes such as xanthine oxidase,
peroxidase and nitric oxide synthase, which are sup-
posed to be involved in free radical generation, thereby
resulting in decreased oxidative damage of macromole-
cules [38]. So the present results suggested that the
probable mechanism of SAME for hepatorenal protec-
tion may be attributed for its free radical scavenging
and antioxidant activity of its phenolics and flavonoids
components [20,35]. Similar protective effects of
Sonchus asper have been recorded in other studies [39].
Another effect of SAME is the protection of DNA of
hepatorenal tissues which was significantly increased
with gentamicin treatment to rats for 10 days. SAME
probably reduces the oxidative damage to DNA by its
putative antioxidant activities [16].
As the SAME is derived from herb, that is commonly
used as vegetable and salad. Therapeutic effects of
SAME may be attributed by the presence of different
dietary polyphenolics. Due to the low solubility of flavo-
noid aglycones in water, to the short residence time of
flavonoids in the intestine, and to the low coefficient of
absorption, it is not possible for humans to suffer acute
toxic effects from the consumption of flavonoids, with
the exception of a rare occurrence of allergy [40]. We
are of the opinion that the use of SAME in clinics may
not cause any kind of side effects.
Conclusion
Dietary polyphenols present in the SAME exhibit hepato
and nephroprotective activities probably through free
radical scavenging properties. Altered level of hepatic
m a r k e r ss u c ha sA S T ,A L T ,A L Pa n dL D Hw i t hg e n t a -
micin exposure was reversed towards normalization
with SAME. Similarly, biochemical and urine parameters
were also restored by SAME. These effects probably
involve multiple molecular and biochemical mechanisms
regulated by polyphenolics. Bioactive components of
SAME ameliorated the oxidative damage and had
increased the regenerative and reparative capacity of
liver and kidneys. So it is mandatory to explore the
Figure 3 Microphotographs of different experimental groups
showing the histopathology of renal tissues. (A) Normal
structure of glomerulus, Bowman capsule (BC), proximal tubules (PT)
and distal tubules (DT). (B) Alterations induced with gentamicin (100
mg/kg bw) in renal tissues; congested proximal tubules (PTC),
leucocytes infiltration (LI). (C) Degeneration of bowman capsule and
glomerulus (DBC), tubular necrosis (NT) with gentamicin
nephrotoxicity. (D) Gentamicin induced leucocyte infiltration in
medullary region (LI). (E) Regeneration of tubules (RT) and mild
leucocyte infiltration (LI) with SAME (100 mg/kg bw) in combination
with gentamicin. (F) normal architecture of proximal tubule (PT) and
distal tubule (DT) with SAME (200 mg/kg bw) along with
gentamicin.
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Page 8 of 9bioactive chemicals in SAME in order to develop the
therapeutics that have a promising role in the treatment
of hepatorenal dysfunction diseases induced by
xenobiotics.
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